ACHE and myasthenia gravis: Third, as indicated by the risk of bias analysis, several studies failed to report key data on patients’ demographic and disease characteristics (e.g., MG classification, MG severity, duration of treatment, and type of treatment (acetylcholinesterase inhibitors, steroid treatment, non-steroid immunosuppressive treatment)) in relation to diabetes prevalence.